<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02895165</url>
  </required_header>
  <id_info>
    <org_study_id>001377;000650</org_study_id>
    <nct_id>NCT02895165</nct_id>
  </id_info>
  <brief_title>PREgnancy and FERtility Registry</brief_title>
  <acronym>PREFER</acronym>
  <official_title>An Italian Multicenter Prospective Cohort Study on Fertility Preservation and Pregnancy Issues in Young Breast Cancer Patients: PREgnancy and FERtilty (PREFER)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinical Research Technology S.r.l.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PREgnancy and FERtility (PREFER) study is a comprehensive program aiming to optimize care
      and improve knowledge around the topics of fertility preservation and pregnancy issues in
      young breast cancer patients. The program was initiated at the National Institute for Cancer
      Research, IRCCS AOU San Martino - IST in Genova (Liguria Region, Italy) and then it has been
      spread to other Italian Institutions under the umbrella of the Gruppo Italiano Mammella (GIM)
      study group. It is composed of two distinctive studies, one assessing fertility (i.e.
      PREFER-FERTILITY) and the other pregnancy (PREFER-PREGNANCY) issues. Hence, two different
      study protocols were developed under the umbrella of the PREFER registry.

      PREFER-FERTILITY aims to obtain and centralize data about the preferences and choices of
      young cancer patients on the fertility preservation strategies available in Italy.
      Furthermore, it aims to assess the outcomes of patients undergoing one or more strategies for
      fertility preservation in terms of success of the techniques (i.e. recovery of ovarian
      function, number of cryopreserved oocytes, post-treatment pregnancies) and safety (i.e.
      long-term survival outcomes).

      PREFER-PREGNANCY has two main objectives: 1) to obtain and centralize data on the management
      of breast cancer diagnosed during pregnancy, the obstetrical and paediatric care of children
      born after prior in utero exposure to anticancer treatments, and the long-term survival
      outcomes of these patients; 2) to obtain and centralize data on the clinical outcomes of
      breast cancer survivors that achieve a pregnancy after prior diagnosis and treatment of
      breast cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2032</completion_date>
  <primary_completion_date type="Anticipated">November 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>15 Years</target_duration>
  <primary_outcome>
    <measure>Rate of patients interested in the available strategies for fertility preservation</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed through medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of patients undergoing the different strategies for fertility preservation</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed through medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Type of strategies for fertility preservation proposed by oncologists</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed through medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reasons for refusal of the available strategies for fertility preservation</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed through an open questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Type of anticancer therapies administered during pregnancy</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed through medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety: pregnancy complications</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed through medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety: incidence of adverse events</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed through medical records</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>15 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success of the available strategies for fertility preservation: rate of recovery of ovarian function after antitumor treatments</measure>
    <time_frame>15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success of the available strategies for fertility preservation: number of oocytes collected and cryopreserved</measure>
    <time_frame>15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success of the available strategies for fertility preservation: number of pregnancies achieved after breast cancer treatments</measure>
    <time_frame>15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum hormonal changes during chemotherapy and study follow up</measure>
    <time_frame>15 years</time_frame>
    <description>FSH (follicle stimulating hormone), estradiol and AMH (anti-mullerian hormone) serum levels assessed at baseline, during chemotherapy, at the end of chemotherapy and every six months thereafter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstetrical and paediatric care of children born after prior in utero exposure to anticancer treatments</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed using obstetric and paediatric medical records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstetrical and paediatric care of children born in breast cancer survivors</measure>
    <time_frame>15 years</time_frame>
    <description>Assessed using obstetric and paediatric medical records</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Breast Neoplasms</condition>
  <condition>Pregnancy</condition>
  <condition>Fertility Preservation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Young breast cancer patients facing fertility and pregnancy issues
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  breast cancer diagnosis

          -  age between18 and 45 years (only for PREFER-FERTILITY)

          -  have not received any radiation or chemotherapy for cancer before enrolment (only for
             PREFER-FERTILITY)

          -  absence of metastatic disease (only for PREFER-FERTILITY)

          -  diagnosis of breast cancer during pregnancy or within 1 year from the end of pregnancy
             or pregnancy after prior diagnosis and treatment for breast cancer (only for
             PREFER-PREGNANCY)

          -  informed consent

        Exclusion Criteria:

          -  inability to provide written informed consent

          -  stage IV disease at diagnosis (only for PREFER-FERTILITY)

          -  serious psychiatric disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lucia Del Mastro, MD</last_name>
    <phone>+390105558908</phone>
    <email>lucia.delmastro@hsanmartino.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Presidio Ospedaliero `Antonio Perrino`</name>
      <address>
        <city>Brindisi</city>
        <state>BR</state>
        <zip>72100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saverio Cinieri, MD</last_name>
      <phone>00390831537219</phone>
      <email>saverio.cinieri@ieo.it</email>
    </contact>
    <investigator>
      <last_name>Saverio Cinieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU di Cagliari Strada</name>
      <address>
        <city>Monserrato</city>
        <state>Cagliari</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Croce e Carle</name>
      <address>
        <city>Cuneo</city>
        <state>CN</state>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ornella Garrone, MD</last_name>
      <phone>00390171616350</phone>
      <email>ornella.garrone@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ornella Garrone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arcispedale S. Anna - A.O.U. di Ferrara</name>
      <address>
        <city>Cona</city>
        <state>FE</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Frassoldati, MD</last_name>
      <phone>00390532239209</phone>
      <email>a.frassoldati@ospfe.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Frassoldati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Irccs Aou San Martino - Ist</name>
      <address>
        <city>Genoa</city>
        <state>GE</state>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Del Mastro, MD</last_name>
      <phone>00390105600387</phone>
      <email>lucia.delmastro@hsanmartino.it</email>
    </contact>
    <investigator>
      <last_name>Lucia Del Mastro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matteo Lambertini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <state>LE</state>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariangela Ciccarese, MD</last_name>
      <phone>00390832661962</phone>
      <email>m.ciccarese@libero.it</email>
    </contact>
    <investigator>
      <last_name>Mariangela Ciccarese, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Unico Versilia</name>
      <address>
        <city>Lido di Camaiore</city>
        <state>LU</state>
        <zip>55041</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenico Amoroso, MD</last_name>
      <phone>003905846057208</phone>
      <email>d.amoroso@usl12.toscana.it</email>
    </contact>
    <investigator>
      <last_name>Domenico Amoroso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Carlo Poma</name>
      <address>
        <city>Mantova</city>
        <state>MN</state>
        <zip>46100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Giovanna Cavazzini, MD</last_name>
    </contact>
    <investigator>
      <last_name>Maria Giovanna Cavazzini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale `Guglielmo da Saliceto`</name>
      <address>
        <city>Piacenza</city>
        <state>PC</state>
        <zip>29121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fondazione S. Maugeri IRCCS</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Bernardo, MD</last_name>
      <phone>00390382592640</phone>
      <email>antonio.bernardo@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Bernardo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Carlo</name>
      <address>
        <city>Potenza</city>
        <state>PZ</state>
        <zip>85100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenico Bilancia, MD</last_name>
    </contact>
    <investigator>
      <last_name>Domenico Bilancia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Regina Elena per lo studio e la cura dei tumori</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera n. 1 - Annunziata</name>
      <address>
        <city>Sassari</city>
        <state>SS</state>
        <zip>07100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Pazzola, MD</last_name>
      <phone>00390792061556</phone>
      <email>oncologia.medica@aslsassari.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Pazzola, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione del Piemonte per l'Oncologia - IRCC di Candiolo</name>
      <address>
        <city>Candiolo</city>
        <state>TO</state>
        <zip>10060</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Filippo Montemurro, MD</last_name>
      <phone>﻿00390119933250</phone>
      <email>filippo.montemurro@ircc.it</email>
    </contact>
    <investigator>
      <last_name>Filippo Montemurro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU SM Misericordia</name>
      <address>
        <city>Udine</city>
        <state>UD</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio Puglisi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Sacro Cuore Don Calabria</name>
      <address>
        <city>Negrar</city>
        <state>VE</state>
        <zip>37024</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefania Gori, MD</last_name>
      <phone>00390456013472</phone>
      <email>stefania.gori@sacrocuore.it</email>
    </contact>
    <investigator>
      <last_name>Stefania Gori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Cardinal Massaia</name>
      <address>
        <city>Asti</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Testore</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Federico II</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabino De Placido, MD</last_name>
      <phone>00390817463650</phone>
      <email>studiclinici.oncologia@unina.it</email>
    </contact>
    <investigator>
      <last_name>Sabino De Placido, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale dei Tumori - Fondazione G.Pascale</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelino De Laurentiis, MD</last_name>
      <phone>00390815454999</phone>
      <email>m.delaurentiis@breastunit.org</email>
    </contact>
    <investigator>
      <last_name>Michelino De Laurentiis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria della Misericordia</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crinò</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Pisana - Ospedale S. Chiara</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelotti</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arcispedale Santa Maria Nuova di Reggio Emilia</name>
      <address>
        <city>Reggio Emilia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>La Sala</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASS1 Triestina</name>
      <address>
        <city>Trieste</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ceccherini</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2016</study_first_submitted>
  <study_first_submitted_qc>September 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</investigator_affiliation>
    <investigator_full_name>Lucia Del Mastro,MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>breast neoplasms</keyword>
  <keyword>fertility preservation</keyword>
  <keyword>pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

